Skip to main content
    E

    Evotec SE ADR (EVO)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $1.48
    -0.08 (-5.13%)

    Market Cap: $561.51M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Evotec SE ADR (EVO) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Evotec SE ADR (EVO) has a latest price of $1.48 on Nov 17, 2026, 61.8% below its 52-week high of $3.87. Its price fell 51.0% over the past 12 months. The month-end price fell 43.6% over the 10 years through Oct 2026, a compound annual decline of 5.6%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $25.01 in Aug 2021 and its lowest $1.53 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart EVO with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for EVO.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 25.3%, and over 6 months it fell 46.8%. The month-end price fell 82.2% over the 3 years through Oct 2026, a compound annual decline of 43.8%.

    PeriodChange
    1 month+4.2%
    3 months-25.3%
    6 months-46.8%
    12 months-51.0%
    12 months, with dividends-51.0%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-82.2%-43.8%
    5 years-93.6%-42.3%
    10 years-43.6%-5.6%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price rose 106.2%, and its weakest was 2022, when it fell 65.9%.

    YearCloseChange
    2026 through Oct 2026$1.53-50.3%
    2025$3.08-26.0%
    2024$4.16-64.5%
    2023$11.73+45.0%
    2022$8.09-65.9%
    2021$23.75+29.4%
    2020$18.35+42.8%
    2019$12.85+29.0%
    2018$9.96+24.1%
    2017$8.03+106.2%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 6.6% below its 50-day average of $1.58 and 38.4% below its 200-day average of $2.40.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$1.48
    52-week high$3.87-61.8%
    52-week low$1.33+11.3%
    50-day average$1.58-6.6%
    200-day average$2.40-38.4%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 88.7%.

    MeasureValue
    1-year beta1.15
    Largest fall, 1 year-65.2%
    Largest fall, 3 years-88.7%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About EVO

    What is EVO's 1-year price change?

    Evotec SE ADR's price fell 51.0% over the past 12 months. With dividends included, the 12-month total return was -51.0%.

    What is EVO's 5-year price change?

    Evotec SE ADR's month-end price fell 93.6% over the 5 years through Oct 2026, a compound annual decline of 42.3%. These figures leave out dividends.

    What is EVO's 52-week high and low?

    Evotec SE ADR's 52-week high is $3.87 and its 52-week low is $1.33. Its latest price of $1.48 on Nov 17, 2026 is 61.8% below the high.

    What is EVO's beta?

    Evotec SE ADR's 1-year beta against the S&P 500 is 1.15, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 65.2%.

    Is the EVO chart free?

    Yes. Advanced Charting for EVO is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.